These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

109 related items for PubMed ID: 751278

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. A double-blind cross-over study of niflumic acid and indomethacin in rheumatoid arthritis.
    Gulati PD, Lamba S, Rizvi SN, Vaishnava H.
    J Assoc Physicians India; 1975 Dec; 23(12):897-901. PubMed ID: 773919
    [No Abstract] [Full Text] [Related]

  • 4. [Clinical evaluation of the preparation Donalgin in the treatment of rheumatoid arthritis and ankylosing spondylitis].
    Sadkiewicz S, Barwik-Schramm A, Grzywa M, Letkiewicz C, Piotrowska E, Procel Z, Reszkowska H, Wippel A, Woźniak M, Zmudzińska I.
    Reumatologia; 1982 Dec; 20(1-2):75-80. PubMed ID: 6761815
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [The long term treatment of rheumatoid arthritis with niflumic acid or indometazin in double blind controlled trial (author's transl)].
    Rejholec V.
    Med Klin; 1976 Jul 09; 71():1188-91. PubMed ID: 822265
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [The uses of sequential analysis for statistical evaluation of some criteria in a double-blind clinical trial].
    Pavelka K, Kanková D, Vojtísek O.
    Fysiatr Revmatol Vestn; 1975 Dec 09; 53(6):326-8. PubMed ID: 765249
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [Controlled clinical study on the use of morniflumate in the treatment of inflammatory-degenerative diseases of the locomotor system].
    Raffaetà G, Saponati G, Terzuoli A.
    G Clin Med; 1987 Oct 09; 68(10):507-13. PubMed ID: 3428515
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [Clinical study of the beta-morpholinoethylester of niflumic acid in children's dentistry].
    Benoit P, Michelet FX, Benoit JP.
    Rev Odontostomatol Midi Fr; 1975 Oct 09; (4):249-61. PubMed ID: 1236592
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Niflumic acid in rheumatoid arthritis: a pilot study.
    Palmer DG, Moller PW, Highton TC.
    N Z Med J; 1972 Jun 09; 75(481):351-2. PubMed ID: 4508430
    [No Abstract] [Full Text] [Related]

  • 17. Combined drug treatment of neurological inflammatory processes.
    Perényi G.
    Ther Hung; 1981 Jun 09; 29(4):186-90. PubMed ID: 7188145
    [No Abstract] [Full Text] [Related]

  • 18. [Comparative trial by double-blind method of a niflumic acid derivative and oxyphenbutazone in pediatric O. R. L].
    Traissac L, Roche JC.
    Rev Laryngol Otol Rhinol (Bord); 1979 Jun 09; 100(1-2):151-61. PubMed ID: 379941
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [Fluorine osteosis caused by a very long-term niflumic acid treatment in 2 cases of rheumatoid arthritis].
    Prost A, Boiteau HL, Gaillard F, Hamelin JP, Carlier N, Rossel-Renac F.
    Rev Rhum Mal Osteoartic; 1978 Dec 09; 45(12):707-16. PubMed ID: 107572
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.